Literature DB >> 2306886

Hereditary long QT syndrome in the postoperative cardiac patient.

T Klitzner1.   

Abstract

The purpose of the present article is to evaluate the diagnostic implications of the long QT syndrome presenting in postoperative cardiac patients. Diagnosis of long QT syndromes may be complicated by an inability to measure the QT interval correctly due to postoperative electrocardiographic changes such as right bundle-branch block. For this reason, a study of the effect of right bundle-branch block on the QT interval was undertaken. Electrocardiograms of 17 randomly selected patients undergoing a right ventriculotomy for repair of tetralogy of Fallot were evaluated for QT prolongation pre- and postoperatively. Preoperatively, no patient demonstrated QT interval prolongation. After surgery, however, right bundle-branch block created an apparent prolongation of the QT interval in 9 of the 17 patients (53%). These results suggest that in postoperative cardiac patients QT prolongation and familial long QT syndromes may be difficult to diagnose. It is, therefore, important to exclude the long QT syndrome in patients with ventricular tachycardia even if a more obvious explanation such as previous cardiac surgery is present. Usually a careful family history and preoperative electrocardiogram are all that is required.

Entities:  

Mesh:

Year:  1990        PMID: 2306886     DOI: 10.1002/clc.4960130215

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  2 in total

1.  Preoperative diagnosis of long QT syndrome in an infant with tetralogy of Fallot.

Authors:  Christoph P Hornik; Michael J Campbell; Michael P Carboni; Andrew J Lodge; John F Rhodes; Ronald J Kanter
Journal:  Pediatr Cardiol       Date:  2011-03-30       Impact factor: 1.655

2.  Post-hoc diagnosis of congenital long QT syndrome in patients with tetralogy of Fallot.

Authors:  J Walls; S Sanatani; R Hamilton
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.